Bioio logo in white
HomeAboutSciencePipelineNewsContact
Link Four
Link FiveLink SixLink Seven

Stay Connected

To learn more about BIOIO or inquire about partnerships or career opportunities, feel free to reach out to us here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News

View all
September 15, 2024

BIOIO validates its in silico Gene2Drug MOAT module in models of Rheumatoid arthritis. MOAT identified a chemical mimic of IKBz inhibition (Pubmed: 39279148).

See more
April 26, 2024

BIOIO adds Ildiko Lingvay, MD, a pioneering clinical trialist for the GLP-1 RAs and Professor at Univ. of Texas Southwestern to its Scientific Advisory Board.

See more
January 26, 2024

Missouri Technology Corporation, a for-profit public private partnership awarded BIOIO seed funding in its January 2024 investment cycle.

See more
January 15, 2023

BIOIO posts BIOIO-1001 manuscript to BioRxiv.

See more
June 29, 2022

BIOIO and LabDAO form partnership to virtualize drug discovery.

See more
May 9, 2022

BIOIO-2001 was funded by VitaDAO using Molecule’s IP-NFT framework.

See more
Bioio logomark
HomeAboutSciencePipelineNewsContact
BIOIO, Inc. 4340 Duncan Ave. St. Louis, MO 63110
info@bioio.tech
© 2024 BIOIO Tech. All rights reserved.
X iconLinkedIn icon